Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 10,783	$ 3,418	$ 26,401	$ 9,941
General and administrative	3,369	2,782	10,984	4,813
Total operating expenses	14,152	6,200	37,385	14,754
Loss from operations	(14,152)	(6,200)	(37,385)	(14,754)
Other income (expense):
Interest income	560	16	898	18
Other income (expense)	4		(2)	(4)
Total other income	564	16	896	14
Net loss	(13,588)	(6,184)	(36,489)	(14,740)
Comprehensive loss:
Net loss	(13,588)	(6,184)	(36,489)	(14,740)
Other comprehensive loss:
Unrealized gain (loss) on securities	14		(712)
Comprehensive loss	$ (13,574)	$ (6,184)	$ (37,201)	$ (14,740)
Net loss per share, basic	$ (0.56)	$ (0.26)	$ (1.49)	$ (1.80)
Net loss per share, diluted	$ (0.56)	$ (0.26)	$ (1.49)	$ (1.80)
Weighted-average shares of common stock outstanding, basic	24,454,786	23,885,017	24,425,390	8,180,359
Weighted-average shares of common stock outstanding, diluted	24,454,786	23,885,017	24,425,390	8,180,359